Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: a systematic review with bayesian and frequentist meta-analysis
P Karakasis, N Stalikas, D Patoulias, K Pamporis… - Trends in …, 2023 - Elsevier
The present systematic review and meta-analysis aimed to investigate the prognostic value
of stress hyperglycemia ratio (SHR) in patients with acute myocardial infarction (AMI). A total …
of stress hyperglycemia ratio (SHR) in patients with acute myocardial infarction (AMI). A total …
Advances in the treatment of functional male hypogonadism
Introduction Functional hypogonadism is frequently found in obese men, particularly those
with metabolic complications. Several possible therapeutic approaches could be …
with metabolic complications. Several possible therapeutic approaches could be …
Long-term comparison of renal and metabolic outcomes after sodium–glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 …
Background Renal outcomes in patients with type 2 diabetes following treatment with
sodium–glucose co-transporter-2 inhibitors (SGLT2is) or glucagon-like peptide-1 receptor …
sodium–glucose co-transporter-2 inhibitors (SGLT2is) or glucagon-like peptide-1 receptor …
A comprehensive meta-analysis on the association of SGLT2is and GLP-1RAs with vascular diseases, digestive diseases and fractures
DH Wang, YX Mo, X Tan, JY Xie, H Wang, F Wen - Acta Diabetologica, 2024 - Springer
Aim Sodium-glucose cotransporter-2 inhibitors (SGLT2is) and glucagon-like peptide 1
receptor agonists (GLP-1RAs) are two new classes of antidiabetic agents. We aimed to …
receptor agonists (GLP-1RAs) are two new classes of antidiabetic agents. We aimed to …
Pancreatic beta‐cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes
JH Moon, HJ Choe, S Lim - Journal of Diabetes Investigation, 2024 - Wiley Online Library
Nowadays, the focus of diabetes treatment has switched from lowering the glucose level to
preserving glycemic homeostasis and slowing the disease progression. The main …
preserving glycemic homeostasis and slowing the disease progression. The main …
Systematic Review of Cardiovascular Outcomes with Sulfonylureas, GLP-1 RA, and DPP-4 Inhibitors in Type 2 Diabetes Mellitus
KT Hau, M Mafauzy, LX Bin - Journal of Diabetology, 2024 - journals.lww.com
Type 2 diabetes mellitus (T2DM) significantly increases the risk of cardiovascular diseases.
Despite advances in glycemic control, managing cardiovascular risk remains a critical …
Despite advances in glycemic control, managing cardiovascular risk remains a critical …
[引用][C] Cardiovascular outcome with SGLT2i and GLP1RA
Dear editor, After the US Food and Drug Administration requested proof of cardiovascular
safety of novel antihyperglycemic medications [1], large cardiovascular outcome trials …
safety of novel antihyperglycemic medications [1], large cardiovascular outcome trials …
[引用][C] Semaglutide and cancer: A systematic review and meta-analysis
Y Xiao - Diabetes & Metabolic Syndrome: Clinical Research & …, 2023 - Elsevier